1
0
0
(1 - 16 von 18
)
minutes of the 9th European MCL Network conferenceTaylor & Francis Online
www.tandfonline.com
von M Dreyling · · Zitiert von: 25 — Eva Hoster Department of Medicine III, University Hospital Großhadern/LMU Munich, Germany. ,. Silvia Bea Hematopathology Unit, Department of Pathology, ...
Author(s) - EHA Library - European Hematology Association
library.ehaweb.org
Eva Hoster. ,. Eva Hoster. Affiliations: Institute for Medical Information Processing, Biometry, and Epidemiology, University of Munich,Munich,Germany. › eha
clinical outcome of mantle cell lymphoma patients with high ...
library.ehaweb.org
Eva Hoster. ,. Eva Hoster. Affiliations: Dept. of Medicine III,University Hospital/LMU Munich,Munich,Germany. Michael Unterhalt. ,. Michael Unterhalt. › eha
Long‐term outcome in patients with mantle cell lymphoma ...John Wiley
onlinelibrary.wiley.com
AP — Eva Hoster,. Eva Hoster. Department of Internal Medicine III, University Hospital Munich, Grosshadern, Germany.
Medline ® Abstract for Reference 105 of 'Clinical UpToDate
www.uptodate.com
AD: Eva Hoster, Roswitha Forstpointner, Wolfgang Hiddemann, Martin H. Dreyling, and Michael Unterhalt, University Hospital Munich; Eva Hoster, University of ... › contents
Validation of POD24 as a robust early clinical end point of ...
ashpublications.org
von C Casulo · · Zitiert von: 9 — Eva Hoster,. Eva Hoster. 3Department of Internal Medicine III, Ludwig-Maximilians University Hospital, Campus Grosshadern, Munich, Germany; ... › blood
Ki-67 as a prognostic marker in mantle cell lymphoma ...
link.springer.com
von W Klapper · · Zitiert von: 173 — Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann & Martin Dreyling. Department of Pathology, Radboud University Nijmegen Medical Centre, ... › article
Long-term clinical and molecular remissions in patients with mantle...
link.springer.com
Martin Dreyling. Department of Internal Medicine IIIUniversity of Munich. Eva Hoster,. Eva Hoster. Department of Internal Medicine IIIUniversity ...
MRD response in relapsed/refractory FL after obinutuzumab plus...
www.nature.com
Hospital of the Ludwig-Maximilians University, Munich, Germany. Eva Hoster. Washington University School of Medicine, St Louis, MO, USA.
Hoster, Eva - Medvikwww.medvik.cz › bmc › view
www.medvik.cz
Eva Hoster, Roswitha Forstpointner, Christian Schmidt, Wolfgang Hiddemann, Michael Unterhalt, and Martin H. Dreyling, University Hospital Munich; Eva Hoster ...
Constructing estimands for overall survival within causal frame ...Vivli
vivli.org
Lead Investigator: Eva Hoster, Ludwig-Maximilian University Munich Title of Proposal Research: Constructing estimands for overall survival within causal ...
Mantle Cell Lymphoma International Prognostic Index (MIPI)MDCalc
www.mdcalc.com
Eva Hoster, PhD, is a professor of clinical epidemiology and medical biometry at Ludwig Maximilian University in Munich, Germany.
Prognostic relevance of clinical risk factors in mantle cell lymphoma...
pubmed.ncbi.nlm.nih.gov
Eva Hoster. Affiliation. 1 Department of Internal Medicine III, University Hospital Munich, Munich, Germany. -muenchen.de.
Prognostic Significance of MYC Rearrangement and ...White Rose University Consortium
eprints.whiterose.ac.uk
von A Rosenwald · · Zitiert von: 155 — John Raemaekers, PhD18; Norbert Schmitz, MD19; Fabrice Jardin, PhD20; Wendy B.C. Stevens, MD21; Eva Hoster, PhD22;.
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in ...国立情報学研究所
cir.nii.ac.jp
Eva Hoster: Eva Hoster, Roswitha Forstpointner, Christian Schmidt, Wolfgang Hiddemann, Michael Unterhalt, and Martin H. Dreyling, University Hospital Munich ...
Paper: A Clinicogenetic Risk Model (m7-FLIPI) Prospectively...
ash.confex.com
... PhD1*, Eva Hoster, PhD1,2* and Oliver Weigert, MD12. 1Medical Department III, University Hospital of the Ludwig-Maximilians-University, ...
Alle Infos zum Namen "Eva Hoster"
sortiert nach Relevanz / Datum